Plain-English translation of NCT06132048 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Cystic Fibrosis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing MuCopilot, a free smartphone application designed to help people with cystic fibrosis monitor their lung health and exercise capacity from home. The app collects objective measurements about your cough, shortness of breath, and walking ability, as well as your symptom experiences—all through simple digital tests you can do on your phone between regular clinic visits. The study wants to make sure the app is easy to use and safe.
Currently, people with cystic fibrosis must come to the clinic in person to get their lung function tested. This medication aims to give patients a way to track important health measures at home, which could help catch changes earlier and reduce the need for frequent clinic visits.
You likely qualify if…
You likely don't qualify if…
You will have two visits in France. At your first visit, you'll meet with the study team and download the free MuCopilot app to your phone. At your second visit (about 1.5 hours long), you'll use the app to complete three simple digital tests that measure your cough, shortness of breath, and walking ability, plus a short symptom questionnaire. The study team will watch to make sure the app works well and is easy for you to use.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
France